I, Endo F, Saya H, et al. (1998) Human ubiquitin-protein ligase Nedd4: expression,
subcellular localization and selective interaction with ubiquitin-conjugating en- zymes. Genes Cells 3:751–763.
Bhattacharya S, Michels CL, Leung MK, Arany ZP, Kung AL, and Livingston DM
(1999) Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1. Genes Dev 13:64 –75.
Bouaboula M, Poinot-Chazel C, Bourrie B, Canat X, Calandra B, Rinaldi-Carmona
M, Le Fur G, and Casellas P (1995) Activation of mitogen-activated protein kinases
by stimulation of the central cannabinoid receptor CB1. Biochem J 312:637– 641.
Breivogel CS, Griffin G, Di Marzo V, and Martin BR (2001) Evidence for a new G
protein-coupled cannabinoid receptor in mouse brain. Mol Pharmacol 60:155–163.
Campbell VA (2001) Tetrahydrocannabinol-induced apoptosis of cultured cortical
neurones is associated with cytochrome c release and caspase-3 activation. Neuropharmacology 40:702–709.
Chemin J, Monteil A, Perez-Reyes E, Nargeot J, and Lory P (2001) Direct inhibition
of T-type calcium channels by the endogenous cannabinoid anandamide. EMBO
(Eur Mol Biol Organ) J 20:7033–7040.
Courtney MJ and Coffey ET (1999) The mechanism of Ara-C-induced apoptosis of
differentiating cerebellar granule neurons. Eur J Neurosci 11:1073–1084.
Currie RW, Ellison JA, White RF, Feuerstein GZ, Wang X, and Barone FC (2000)
Benign focal ischemic preconditioning induces neuronal Hsp70 and prolonged
astrogliosis with expression of Hsp27. Brain Res 863:169 –181.
Derocq JM, Jbilo O, Bouaboula M, Segui M, Clere C and Casellas P (2000) Genomic
and functional changes induced by the activation of the peripheral cannabinoid
receptor CB2 in the promyelocytic cells HL-60. Possible involvement of the CB2
receptor in cell differentiation. J Biol Chem 275:15621–15628.
Devane WA, Dysarz FA, 3rd, Johnson MR, Melvin LS and Howlett AC (1988)
Determination and characterization of a cannabinoid receptor in rat brain. Mol
Pharmacol 34:605– 613.
Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D,
Mandelbaum A, Etinger A, and Mechoulam R (1992) Isolation and structure of a
brain constituent that binds to the cannabinoid receptor. Science (Wash DC)
258:1946 –1949.
Di Marzo V, Goparaju SK, Wang L, Liu J, Batkai S, Jarai Z, Fezza F, Miura GI,
Palmiter RD, Sugiura T, et al. (2001) Leptin-regulated endocannabinoids are
involved in maintaining food intake. Nature (Lond) 410:822– 825.
Gomez del Pulgar T, Velasco G, and Guzman M (2000) The CB1 cannabinoid receptor
is coupled to the activation of protein kinase B/Akt. Biochem J 347:369 –373.
Greenberg SA (2001) DNA microarray gene expression analysis technology and its
application to neurological disorders. Neurology 57:755–761.
Hajos N, Ledent C, and Freund TF (2001) Novel cannabinoid-sensitive receptor
mediates inhibition of glutamatergic synaptic transmission in the hippocampus.
Neuroscience 106:1– 4.
Hillard CJ (2000) Endocannabinoids and vascular function. J Pharmacol Exp Ther
294:27–32.
Howard AD, Wang R, Pong SS, Mellin TN, Strack A, Guan XM, Zeng Z, Williams DL
Jr, Feighner SD, Nunes CN, et al. (2000) Identification of receptors for neuromedin
U and its role in feeding. Nature (Lond) 406:70 –74.
Jamshidi N and Taylor DA (2001) Anandamide administration into the ventromedial
hypothalamus stimulates appetite in rats. Br J Pharmacol 134, 1151–1154.
Jarai Z, Wagner JA, Varga K, Lake KD, Compton DR, Martin BR, Zimmer AM,
Bonner TI, Buckley NE, Mezey E, et al. (1999) Cannabinoid-induced mesenteric
vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc
Natl Acad Sci USA 96:14136 – 41.
Kittler JT, Grigorenko EV, Clayton C, Zhuang SY, Bundey SC, Trower MM, Wallace
D, Hampson R, and Deadwyler S (2000) Large-scale analysis of gene expression
changes during acute and chronic exposure to 9-THC in rats. Physiol Genomics
3:175–185.
Munro S, Thomas KL, and Abu-Shaar M (1993) Molecular characterization of a
peripheral receptor for cannabinoids. Nature (Lond) 365:61– 65.
Nagayama T, Sinor AD, Simon RP, Chen J, Graham S, Jin K, and Greenberg DA
(1999) Cannabinoids and neuroprotection from global and focal cerebral ischemia
and in vitro. J Neurosci 19:2987–2995.
Nakayama T, Yaoi T, Yasui M, and Kuwajima G (1998) N-copine: a novel two
C2-domain-containing protein with neuronal activity-regulated expression. FEBS
Lett 428:80 – 84.
Pan Y, Lloyd C, Zhou H, Dolich S, Deeds J, Gonzalo JA, Vath J, Gosselin M, Ma J,
Dussault B, et al. (1997) Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature (Lond) 387:611– 617.
Panikashvili D, Simeonidou C, Ben-Shabat S, Hanus L, Breuer A, Mechoulam R, and
Shohami E (2001) An endogenous cannabinoid (2-AG) is neuroprotective after
brain injury. Nature (Lond) 413:527–531.
Pennaneach V, Salles-Passador I, Munshi A, Brickner H, Regazzoni K, Dick F,
Dyson N, Chen TT, Wang JY, Fotedar R, et al. (2001) The large subunit of
replication factor C promotes cell survival after DNA damage in an LxCxE motifand Rb-dependent manner. Mol Cell 7:715–727.
Pertwee RG (1997) Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol
Ther 74:129 –180.
Robson P (2001) Therapeutic aspects of cannabis and cannabinoids. Br J Psychiatry
178:107–115.
Roncero I, Alvarez E, Vazquez P, and Blazquez E (2000) Functional glucokinase
isoforms are expressed in rat brain. J Neurochem 74:1848 –1857.
Sanchez C, Rueda D, Segui B, Galve-Roperh I, Levade T, and Guzman M (2001) The
CB(1) cannabinoid receptor of astrocytes is coupled to sphingomyelin hydrolysis
through the adaptor protein fan. Mol Pharmacol 59:955–959.
Shen M and Thayer SA (1998) Cannabinoid receptor agonists protect cultured rat
hippocampal neurons from excitotoxicity. Mol Pharmacol 54:459 – 462.
Sinor AD, Irvin SM, and Greenberg DA (2000) Endocannabinoids protect cerebral
cortical neurons from in vitro ischemia in rats. Neurosci Lett 278:157–160.
